Consumption of caffeinated and decaffeinated coffee enriched with cocoa and fructo-oligosaccharides among non-diabetic persons: Double blind randomized clinical trial.

Autor: Moura de Araújo MF; Health Family, Oswaldo Cruz Foundation, Eusébio, Brazil., Gueiros Gaspar MW; Nursing Department, University for International Integration Lusophony Afro Brazilian, Redenção, Brazil., Saraiva Veras V; Nursing Department, University for International Integration Lusophony Afro Brazilian, Redenção, Brazil., Freire de Freitas RWJ; Health Family, Oswaldo Cruz Foundation, Eusébio, Brazil., de Paula MDL; Pharmacy Department, University of Maranhão, São Luís, Brazil., Alves de Oliveira Serra MA; Nursing Department, Federal University of Maranhão, Imperatriz, Brazil., Garcia Lira Neto JC; Medicine Department, Universidade de Ribeirão Preto, Ribeirão Prêto, Brazil., Coelho Damasceno MM; Nursing Department, Nursing, Dentist and Pharmacy Faculty, Ceará Federal University, Fortaleza, Brazil., Bandeira Moreira AV; Nutrition Department, Juiz de Fora Federal University, Juiz de Fora, Brazil., Derenji de Mello V; Institute of Public Health and Clinical Nutrition, Eastern University of Finland, Kuopio, Finland.
Jazyk: angličtina
Zdroj: Journal of food biochemistry [J Food Biochem] 2022 May; Vol. 46 (5), pp. e14081. Date of Electronic Publication: 2022 Jan 21.
DOI: 10.1111/jfbc.14081
Abstrakt: Food industry has been investing in bringing to the market coffee-based drinks enriched in compounds that promise weight loss, which consequently influences diabetes risk. However, there are no clinical trials showing the effects of brewed coffee (with or without caffeine) enriched with bioactive compounds on body fat and glycemic control in healthy individuals. Therefore, we have evaluated the effect of consuming two coffee formulas enriched with cocoa and fructo-oligosaccharides (FOS) on glycemic and anthropometric biomarkers and blood pressure in non-diabetic adults for 10 weeks. In general, we observed that the values of fasting plasma glucose (FPG) (p = .006) and fasting capillary blood glucose (FCBG) (p < .001) had lower values with a tendency to decrease in FCG (p = .003) and FBG (p < .005) in both formulas. We observed statistically significant reductions in waist circumference (WC) (p = .012), arm circumference (AC) (p = .015), and percentage of fat (<0.0001) for all participants. However, we noticed a greater reduction in the caffeinated formula group (-2.92%, p = .005) compared to the decaffeinated formula (-1.62%, p = .008). Consumers of both cocoa and FOS-enriched coffee formulas benefited from reduced FBG, FCG, WC, and body fat percentage. The consumption of caffeinated formula was more effective in reducing the percentage of fat, while the decaffeinated formula was more effective in reducing diastolic blood pressure. PRACTICAL APPLICATIONS: This study provides robust evidence that effects of fortified coffee on non-diabetic people is positive for reduction in blood glucose, body fat and diastolic blood pressure. This study proposes a practical and safe coffee formulation for the consumption of caffeinated and decaffeinated coffee for non-diabetic people.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje